M. Dinan

发表

Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review

V. Hasselblad, G. Sanders, E. Myers, 2013, Cancer Epidemiology, Biomarkers & Prevention.

Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006.

A. Abernethy, K. Schulman, E. Patz, 2010, JAMA.

Management of chemotherapy-induced neutropenia: measuring quality, cost, and value.

Gary H Lyman, B. Hirsch, G. Lyman, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer

S. Roman, J. Sosa, M. Dinan, 2016, Endocrine.

Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer.

S. Roman, T. Hyslop, J. Sosa, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Extent of Surgery for Papillary Thyroid Cancer Is Not Associated With Survival: An Analysis of 61,775 Patients

S. Roman, D. Tyler, J. Sosa, 2014, Annals of surgery.

Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer.

S. Roman, J. Sosa, M. Dinan, 2015, The Journal of clinical endocrinology and metabolism.

Diagnosis Change in Voice-Disordered Patients Evaluated by Primary Care and/or Otolaryngology

N. Roy, M. Dinan, M. Courey, 2014, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Otolaryngology utilization of speech‐language pathology services for voice disorders

N. Roy, M. Dinan, Seth M. Cohen, 2016, The Laryngoscope.

Opioid prescribing and use among cancer survivors: A mapping review of observational and intervention studies.

Aaron N. Winn, D. Check, A. Kamal, 2021, Journal of pain and symptom management.

Comparison of Conflict of Interest Policies and Reported Practices in Academic Medical Centers in the United States

K. Weinfurt, K. Schulman, M. Hall, 2006, Accountability in research.

Patterns of use and cost for inappropriate radioactive iodine treatment for thyroid cancer in the United States: use and misuse.

S. Roman, J. Sosa, M. Dinan, 2015, JAMA internal medicine.

Resource Use in the Last Year of Life Among Patients Who Died With Versus of Prostate Cancer.

L. Curtis, D. George, S. Reed, 2016, Clinical genitourinary cancer.

Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer.

C. Gross, Xiaomei Ma, M. Dinan, 2022, JAMA oncology.

Advanced imaging and hospice use in end-of-life cancer care

L. Curtis, W. Cheung, S. Setoguchi, 2018, Supportive Care in Cancer.

Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer.

W. Lee, T. Robinson, S. Reed, 2015, Journal of palliative medicine.

Patient- And Provider-Level Predictors of Survival Among Patients With Metastatic Renal Cell Carcinoma Initiating Oral Anticancer Agents.

C. Gross, Melissa A. Greiner, D. George, 2022, Clinical genitourinary cancer.

Treatment at Integrated Centers Might Bridge the Academic-Community Survival Gap in Patients With Metastatic Non-Small Cell Carcinoma of the Lung.

J. Crawford, M. Dinan, S. Ramalingam, 2021, Clinical lung cancer.

Robotic Thyroidectomy for Cancer in the US: Patterns of Use and Short-Term Outcomes

S. Roman, J. Sosa, S. Reed, 2014, Annals of Surgical Oncology.

Extent of surgery for low-risk thyroid cancer in the elderly: Equipoise in survival but not in short-term outcomes.

S. Roman, T. Hyslop, J. Sosa, 2019, Surgery.

Low-Risk Thyroid Cancer in Elderly: Total Thyroidectomy/RAI Predominates but Lacks Survival Advantage.

S. Roman, T. Hyslop, J. Sosa, 2019, The Journal of surgical research.

Survival Comparison in Patients with Stage IV Lung Cancer in Academic versus Community Centers in the United States

J. Crawford, M. Dinan, S. Ramalingam, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Commentary: Personalized Health Planning and the Patient Protection and Affordable Care Act: An Opportunity for Academic Medicine to Lead Health Care Reform

L. Simmons, R. Snyderman, M. Dinan, 2010, Academic medicine : journal of the Association of American Medical Colleges.

overcome such limitations. Thus, retrospective population-based re- search should continue to examine these important issues.

A. Abernethy, K. Schulman, E. Patz, 2013 .

Reply to M.S. Hofman et al.

A. Abernethy, K. Schulman, E. Patz, 2013, Journal of Clinical Oncology.

Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer.

W. Lee, T. Robinson, S. Reed, 2013, Journal of palliative medicine.

Predictors of Chronic Opioid Use: A Population-Level Analysis of North Carolina Cancer Survivors Using Multi-Payer Claims

D. Check, K. Oeffinger, T. Robinson, 2021, Journal of the National Cancer Institute.

Effects of Disclosing Financial Interests on Attitudes Toward Clinical Research

K. Weinfurt, M. Hall, J. Sugarman, 2008, Journal of General Internal Medicine.

Oncology clinical trials

P. Müller, T. Lai, G. Rosner, 2013 .

Proposal for Value-Based, Tiered Reimbursement for Tumor Biomarker Tests to Promote Innovation and Evidence Generation.

R. Schilsky, G. Lyman, D. Hayes, 2019, JCO precision oncology.

Perspectives of clinical research coordinators on disclosing financial conflicts of interest to potential research participants

K. Weinfurt, K. Schulman, J. Sugarman, 2007, Clinical trials.

Disclosing Conflicts of Interest in Clinical Research: Views of Institutional Review Boards, Conflict of Interest Committees, and Investigators

K. Weinfurt, M. Hall, J. Sugarman, 2006, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.

Association between cognitive impairment and oral anticancer agent use in older patients with metastatic renal cell carcinoma

Melissa A. Greiner, M. Dinan, Lauren E Wilson, 2022, Journal of the American Geriatrics Society.

Costs, effectiveness, and workload impact of management strategies for women with an adnexal mass.

E. Myers, L. Curtis, L. Havrilesky, 2015, Journal of the National Cancer Institute.

Trends in hospital-physician integration in medical oncology.

K. Schulman, M. Dinan, J. Clough, 2017, The American journal of managed care.

Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure.

K. Weinfurt, M. Hall, J. Sugarman, 2006 .

Quality, Cost, and Value Management of Chemotherapy-Induced Neutropenia: Measuring

B. Hirsch, G. Lyman, M. Dinan, 2015 .

Racial and Ethnic Variation in COVID-19 Vaccination Uptake Among Medicare Beneficiaries with Cancer History

S. Jeon, M. Dinan, LaRon E Nelson, 2022, Journal of racial and ethnic health disparities.

Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis.

V. Hasselblad, G. Sanders, E. Myers, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oral contraceptive use for the primary prevention of ovarian cancer.

V. Hasselblad, G. Sanders, E. Myers, 2013, Evidence report/technology assessment.

Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years.

S. Roman, T. Hyslop, J. Sosa, 2015, The Journal of clinical endocrinology and metabolism.

Resource use, costs, and utility estimates for patients with cystic fibrosis with mild impairment in lung function: analysis of data collected alongside a 48-week multicenter clinical trial.

K. Schulman, Li Lin, S. Reed, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Views of potential research participants on financial conflicts of interest barriers and opportunities for effective disclosure

K. Weinfurt, M. Hall, J. Sugarman, 2007, Journal of General Internal Medicine.

Policies of Academic Medical Centers for Disclosing Financial Conflicts of Interest to Potential Research Participants

K. Weinfurt, K. Schulman, M. Hall, 2006, Academic medicine : journal of the Association of American Medical Colleges.

Use of Patient-Reported Outcomes in Randomized, Double-Blind, Placebo-Controlled Clinical Trials

K. L. Compton, K. Weinfurt, K. Schulman, 2011, Medical care.

Minimally Invasive Versus Open Pancreaticoduodenectomy for Cancer: Practice Patterns and Short-term Outcomes Among 7061 Patients.

S. Roman, K. Choudhury, J. Sosa, 2015, Annals of surgery.

SplicerAV: a tool for mining microarray expression data for changes in RNA processing

Timothy J. Robinson, Mark Dewhirst, James L. Pearson, 2010, BMC Bioinformatics.

Reporting of Study Participant Demographic Characteristics and Demographic Representation in Premarketing and Postmarketing Studies of Novel Cancer Therapeutics

C. Gross, J. Wallach, J. Ross, 2021, JAMA network open.

Association of 21-Gene Assay (OncotypeDX) Testing and Receipt of Chemotherapy in the Medicare Breast Cancer Patient Population Following Initial Adoption.

J. Griggs, E. Norton, S. Reed, 2020, Clinical breast cancer.

Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.

G. Lyman, L. Curtis, S. Reed, 2015, JAMA oncology.

Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer

K. Schulman, G. Lyman, S. Reed, 2012, Genetics in Medicine.

Impact of Extent of Surgery on Survival in Patients with Small Nonfunctional Pancreatic Neuroendocrine Tumors in the United States

S. Roman, J. Sosa, S. Reed, 2014, Annals of Surgical Oncology.

Patient, provider, and hospital factors associated with oral anti-neoplastic agent initiation and adherence in older patients with metastatic renal cell carcinoma.

C. Gross, C. Pollack, Melissa A. Greiner, 2022, Journal of geriatric oncology.

How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer.

S. Roman, T. Hyslop, J. Sosa, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment Patterns and Outcomes for Patients with Adrenocortical Carcinoma Associated with Hospital Case Volume in the United States

S. Roman, J. Sosa, S. Reed, 2014, Annals of Surgical Oncology.

Evaluation of mild cognitive impairment and dementia in patients with metastatic renal cell carcinoma.

Melissa A. Greiner, L. Maerz, Deborah R. Kaye, 2022, Journal of geriatric oncology.

Algorithms for prediction of the Oncotype DX recurrence score using clinicopathologic data: a review and comparison using an independent dataset

Michael R. Harowicz, M. Mazurowski, P. Marcom, 2017, Breast Cancer Research and Treatment.

Risk of Acute Thromboembolic Events With Oral Contraceptive Use: A Systematic Review and Meta-analysis

V. Hasselblad, G. Sanders, E. Myers, 2013, Obstetrics and gynecology.

Erratum: Costs and length of stay for patients with and without sickle cell disease after hysterectomy, appendectomy, or knee replacement

M. Telen, S. Reed, M. Dinan, 2011 .

Association between physician characteristics and the use of 21-gene recurrence score genomic testing among Medicare beneficiaries with early-stage breast cancer, 2008–2011

C. Pollack, Melissa A. Greiner, M. Dinan, 2018, Breast Cancer Research and Treatment.

Chemotherapy Costs and 21-Gene Recurrence Score Genomic Testing Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005 to 2011.

S. Reed, M. Dinan, Lauren E. Wilson, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Patient-Centered Communication for Discussing Oncotype DX Testing

M. Weinberger, S. Wheeler, S. Dusetzina, 2016, Cancer investigation.

Oral Contraceptive Pills as Primary Prevention for Ovarian Cancer: A Systematic Review and Meta-analysis

V. Hasselblad, G. Sanders, E. Myers, 2013, Obstetrics and gynecology.

Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003.

Amy P Abernethy, Lesley H Curtis, Morris Weinberger, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Redistribution of Health Care Costs after the Adoption of Positron Emission Tomography among Medicare Beneficiaries with Non–Small-Cell Lung Cancer, 1998–2005

A. Abernethy, K. Schulman, E. Patz, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The effect of increased PET imaging on the staging, outcomes, and health care utilization of Medicare non-small cell lung cancer patients

M. Dinan, 2011 .

Factors Associated With Receipt of Molecular Testing and its Impact on Time to Initial Systemic Therapy in Metastatic Non-Small Cell Lung Cancer.

A. Mosa, D. Check, R. Carnahan, 2023, Clinical lung cancer.

Oral anticancer agent (OAA) adherence and survival in elderly patients with metastatic renal cell carcinoma (mRCC).

C. Gross, Melissa A. Greiner, D. George, 2021, Urology.

Real-World Utilization of Oral Anticancer Agents and Related Costs in Older Adults with Metastatic Renal Cell Carcinoma in the United States

Melissa A. Greiner, D. George, C. Scales, 2021, Kidney cancer.

Variations in use of PET among Medicare beneficiaries with non-small cell lung cancer, 1998-2007.

A. Abernethy, K. Schulman, E. Patz, 2013, Radiology.

Changes in initial treatment for prostate cancer among Medicare beneficiaries, 1999-2007.

K. Schulman, L. Curtis, W. Lee, 2012, International journal of radiation oncology, biology, physics.

Adoption of New Risk Stratification Technologies Within US Hospital Referral Regions and Association With Prostate Cancer Management

C. Gross, Xiaomei Ma, James B. Yu, 2021, JAMA Network Open.

Personalized medicine is more than genomic medicine: confusion over terminology impedes progress towards personalized healthcare.

Leigh Ann Simmons, Ralph Snyderman, L. Simmons, 2012, Personalized medicine.

Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer.

L. Carey, M. Weinberger, M. Troester, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Managing Chronic Pain in Cancer Survivorship: Communication Challenges and Opportunities as Described by Cancer Survivors

T. Somers, D. Check, K. Oeffinger, 2023, The American journal of hospice & palliative care.

Developing model language for disclosing financial interests to potential clinical research participants.

K. Weinfurt, K. Schulman, M. Hall, 2007, IRB.

INITIAL ADOPTION OF RECOMBINANT HUMAN THYROID-STIMULATING HORMONE FOLLOWING THYROIDECTOMY IN THE MEDICARE THYROID CANCER PATIENT POPULATION.

J. Sosa, S. Reed, M. Dinan, 2019, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Concurrent prescribing of opioids with other sedating medications after cancer diagnosis: a population-level analysis

Aaron N. Winn, D. Check, K. Oeffinger, 2022, Supportive Care in Cancer.

Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing

L. Carey, M. Weinberger, M. Troester, 2015, Breast Cancer Research and Treatment.

Relative Burden of Cancer and Noncancer Mortality Among Long-Term Survivors of Breast, Prostate, and Colorectal Cancer in the US

C. Gross, T. Hyslop, A. Justice, 2023, JAMA network open.

Treatment patterns and health care resource use of patients with metastatic breast cancer with HER2-low expression: A cancer registry-linked insurance claims study.

D. Check, S. Wheeler, Bradford E. Jackson, 2022, Journal of Clinical Oncology.

Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.

B. Hirsch, G. Lyman, L. Curtis, 2015, JAMA oncology.

Outcomes of inpatients with and without sickle cell disease after high‐volume surgical procedures

Bradley G Hammill, Shelby D Reed, Chia-Hung Chou, 2009, American journal of hematology.